Abbott today announced the U.S. Food and Drug Administration (FDA) has approved the company's Tendynetm transcatheter mitral valve replacement (TMVR) system to treat people with mitral valve disease.

Scientists engineered a way to deliver genes directly to lung and airway cells using a nasal spray * AAV.CCP.16 -// a viral ...

Here’s how it would work: A nasal mRNA vaccine would be taken as a spray through the nose, coating the nasal passages. The cells in the nasal lining would use the vaccine’s instructions to ...